Since the pioneering work of Hench and co-workers [1] disease activity, circadian extremes of cortisol occurred which demonstrated the anti-inflammatory effects of slightly earlier in the day compared to normal controls. cortisone and adrenocorticotrophic hormone (ACTH )
Patients with low-level disease activity had a lower in patients with rheumatoid arthritis (RA), it has been cortisol profile, while in patients with high disease accepted that corticosteroids are able to alleviate the activity cortisol secretion was elevated with loss of joint inflammation which occurs in RA. A concerted circadian rhythm. These results were important because effort was subsequently made to determine whether the they suggested a resetting of the HPA axis to mount a effects were purely pharmacological, or whether glucogreater anti-inflammatory response associated with corticoid therapy was successful because it was replenincreased disease progression. Thus, HPA axis activity, ishing an underlying deficiency of endogenous cortisol although apparently attenuated in milder forms of the production. However, the results of a number of studies disease, which might suggest a role for a defective HPA over the next two decades proved disappointing. Only axis in the aetiology of RA, nevertheless appeared to be three out of 24 RA patients not previously treated with a dynamic system capable of responding to increased corticosteroids had 24 h urinary cortisol values 'on the disease severity. low side of the normal range', the rest were normal [2] .
Unfortunately, this promising conclusion has not been In 124 patients not receiving steroid therapy, 24 h urinsustained, since a multitude of tests of HPA axis function ary cortisol levels were within the normal range, irrehave failed to pinpoint a defect convincingly or consistspective of the degree of disease severity [3] . Urinary ently confirm a direct correlation between disease activglucocorticoid levels in response to the ACTH test were ity and cortisol secretion. However, some of the data not different in RA patients compared to patients with may be rendered ambiguous by treatment which the non-rheumatic diseases [4, 5] . Researchers also failed to patients received prior to and during the studies. A detect differences between RA patients and controls for normal cortisol, but elevated ACTH, response to the other metabolic parameters such as blood cortisone CRH test in RA patients suggested adrenocortical clearance rate [6 ] or levels of cortisol binding globulin insensitivity [9] , but although these patients were taken (CBG) [7] . By the 1960s, one researcher had concluded off prednisolone for 36 h prior to the study, treatment that 'on consideration of these and other data, it is was maintained with non-steroidal anti-inflammatory apparent that abnormalities in adrenal cortical steroids drugs (NSAIDs), which have since been shown to be are not a major, primary factor in the etiology of associated with decreased plasma ACTH levels in RA rheumatoid arthritis' [5] . By the 1970s, overall inability [10, 11] . Another study also suggested adrenocortical to show convincing hypothalamo-pituitary-adrenal insensitivity, since RA patients had elevated plasma (HPA) axis activity dysfunction in RA led to the ACTH levels with normal serum and 24 h urinary approach being abandoned.
cortisol [10] . Normal ACTH and cortisol responses to Well, not quite abandoned. Since the 1980s, the devel-CRH have been reported in RA patients maintained on opment of the corticotrophin-releasing hormone (CRH ) NSAIDs [12, 13] , but these tests showed very poor test for evaluation of pituitary-adrenal integrity and the responses to CRH in normal subjects compared to an availability of more sensitive and specific assays for early seminal study [14] , and these blunted responses glucocorticoid measurements have launched a reinvestiperhaps masked any differences between RA patients gation into a possible HPA axis defect in RA. Key and controls. A normal diurnal rhythm for plasma observations were made by Neeck and co-workers [8] , cortisol in RA has been reported, with levels towards who, rather than performing 24 h urinary cortisol studthe lower end of the normal range, but not statistically ies, plotted circadian rhythms of plasma cortisol in different to controls [13, 15] . Normal responses to a untreated RA patients. In patients with low to medium low-dose dexamethasone suppression test were observed in 19 out of 20 patients with RA [16 ] .
To minimize the effects of therapy on HPA axis NSAIDs were withdrawn several days prior to the experiment. Basal serum cortisol levels were elevated in sequence of the inflammation, the former interpretation is suggested by a study showing that patients with early pre-menopausal patients with active disease [17] , while RA who later developed the disease had similar plasma adrenocortical insensitivity to the CRH test was reported cortisol profiles at both time points [25] . However, in a by Gudbjornsson et al. [18] in RA patients with moderrecent study [26 ] , plasma ACTH and cortisol levels over ately severe disease activity, since an impaired cortisol a period of 4 days following joint replacement surgery response to the CRH test occurred in spite of normal were not different in RA and OA patients, questioning ACTH levels, which if anything were enhanced. These the existence of an HPA axis defect in RA. A number results are consistent with the study cited above [10] , of groups [27] [28] [29] [30] [31] [32] have used the insulin tolerance test but the experimental groups of seven and 18 RA patients (ITT ) for overall HPA axis integrity in RA, but these in these two studies [10, 18] There are, of course, many circumstances other than has no abnormal biochemical characteristics, there is an an inadequate cortisol output in which a normal HPA inherent defect in its very failure to respond to increased axis response to inflammation could be compromised. inflammation with increased cortisol secretion. In other
The number of glucocorticoid receptors (GR) in words, the HPA axis response in RA is defective precisely lymphocytes from RA patients was lower than in conbecause it is normal. Experimental evidence from studies trols [33] , an observation difficult to explain by downin normal subjects does suggest that HPA axis activity regulation since serum cortisol levels were normal. A should be increased in RA. A significant increase in parallel decrease in GR numbers in the hippocampal early morning plasma levels of interleukin (IL)-6 has and hypothalamic areas, which regulate glucocorticoid been observed in RA patients prior to the increase in feedback of the HPA axis, might have an effect on ACTH or cortisol [20, 22] . Acute injection of IL-6 overall HPA axis function. Familial polymorphisms of potently stimulates HPA axis activity [23] . Therefore it the GR gene affect some 25% of the population, thus has been proposed that ACTH and cortisol should be introducing the potential for a wide range of GR elevated in RA in response to the early morning increases affinities. A GR polymorphism has been associated with in IL-6, but although slight increases were detected [20] , glucocorticoid hypersensitivity in a normal population these were not statistically significant. This may suggest
[34], but there is currently no evidence for GR polya pathological resistance of HPA axis activity to circulatmorphisms specific to RA patients. Polymorphisms have ing IL-6 and/or other cytokines in RA. However, nothbeen found in the CRH gene in several RA patients, ing is currently known of the effects on HPA axis activity which may result in variable regulation of CRH expresof chronic exposure to high levels of cytokines, which sion during RA [35] . Another possible explanation for may result in quite a different profile of HPA axis a defect in the HPA axis response to inflammation might activity compared to that observed in response to acute be that CBG circulates in higher concentrations in RA, administration of cytokines.
which would reduce the amount of bioactive free cortiIn addition to dynamic pharmacological testing, the sol. In a small study, Winter et al. [7] found that levels HPA axis response in RA patients has been challenged of free cortisol and CBG were not different in RA by experimental stressors. Patients with recently diagpatients compared to controls, but further investigation nosed RA had slightly higher baseline morning cortisol is warranted. A pro-inflammatory role has been suglevels than controls, but their response to acute psychogested for CRH [36 ] , and the report of elevated levels logical and physical stressors was normal [24] . An early of CRH immunoreactivity and binding protein in the study found that urinary 17-hydroxycorticosteroid levels synovial fluid of patients with RA, together with were elevated as expected in RA patients in the 24 h increased CRH-binding protein in the blood of RA period after major surgery [3] . More recently, it has patients, may imply an immunomodulatory role for been reported that RA patients failed to show increased these compounds [37] . Pathways of steroid metabolism plasma cortisol 48 h following the stress of major surgery have also been investigated in RA, with reports that compared to osteoarthritic (OA) patients [13] . Since the RA might be associated with enhanced degradation of same study showed a normal HPA axis response to the cortisol into inactive metabolites in inflamed tissues [3] . CRH test, these data suggested an HPA axis defect at This is another area which might prove fruitful to the hypothalamic level in RA. Although it is very resurrect, in the light of our increased knowledge of the difficult to determine whether this putative defect is of kinetics and tissue distribution of the 11b-hydroxysteroid dehydrogenase family of enzymes which aetiological significance in RA or whether it is a con-interconvert cortisol and its inactive metabolite cortis-RA. This is equally true of depression, a syndrome one. It must also be borne in mind that a large number characterized by chronically elevated cortisol which is of steroids other than glucocorticoids are secreted from not clinically associated with remission of RA. One the adrenal cortex [38] , and deficiencies which have explanation may be that the phenomenon of stress is been reported in androgen secretion in RA [39] may extremely complex, involving the stimulated secretion produce a pro-inflammatory environment. Daily testoof a myriad of compounds, many of which, such as sterone treatment was beneficial in one study on male cytokines, b-endorphin, arginine vasopressin and prolac-RA patients [40] . Considerable attention has also tin, may be pro-inflammatory [52] . Thus, the net effects focused on dehydroepiandrosterone (DHEA), low levels of stress may be to exacerbate an inflammatory condiof which have been reported in patients with RA [21, tion, as has been reported for RA [53, 54] . The degree 39, 41]. The clinical implications of this are not clear, to which a stressor may act in a pro-or antisince one group failed to find any beneficial effect of inflammatory way on a pre-existing disease may be DHEA administration in elderly patients with longdetermined by the type of stressor, the specific neurostanding active RA [42] , but full investigation into the chemical pathway(s) activated, and the profile and condynamics of DHEA, DHEA sulphate and cortisol secrecentrations of the compounds secreted into the blood in tion in RA may reveal correlations with disease states.
response. Sex differences in HPA axis responses to stress, To test whether the HPA axis in RA really has a differential secretion of cortisol in female RA patients defective response to the onset of inflammation, it is compared to men [55] , and interactions between the instructive to investigate whether ameliorated inflam-HPA and HP-gonadal axes [56 ] may underlie the predismation is found in RA patients with Cushing's disease position of women to RA. or during pregnancy, conditions which are characterized
In conclusion, most evidence supports the view that by elevated circulating levels of cortisol. The phenom-HPA axis activity in RA patients is not significantly enon of remission of symptoms in~75% of RA patients different from normal subjects, and that any inherent during pregnancy is well recognized [1, 3, 43, 44] , but abnormality lies in the inability of the axis to increase difficult to correlate directly with elevated cortisol cortisol production in response to the onset of inflambecause of the accompanying complex milieu of hormation. However, subtle alterations in cortisol secretion mone secretion from the pituitary, adrenal gland and may occur in RA, either during the diurnal rhythm or placenta. Conditions such as Cushing's or Addison's at certain stages during the onset and progression of diseases, whose sole endocrine dysfunction is inappropridisease. Some groups have observed correlations of ate glucocorticoid secretion, provide a better environserum cortisol and disease activity in RA [8, 17, 55] , ment to determine a causal relationship between circulating cortisol and degree of inflammation in RA.
and a longitudinal study on a population of RA patients Patients with Addison's disease, whose production of from early stages through disease progression might be cortisol may be only 10% of normal, might be expected revealing in this respect. The question of a possible HPA to develop RA en masse if HPA axis deficiency were the axis defect is important in relation to optimizing the vital link, but not all Addisonian patients suffer from therapeutic effects of glucocorticoids through dosage RA. Conversely, patients with Cushing's disease would and timing of administration. Information about glucobe expected to be less susceptible to RA. Several cases corticoid insufficiency at any stage of disease would be of remission in RA have been reported following the invaluable for the timing of glucocorticoid replacement onset of Cushing's disease [45, 46 ] and one instance of therapy for maximum anti-inflammatory effects. This exacerbation occurred after surgical treatment [47] , but may also permit doses of glucocorticoids and their no epidemiological investigation has been performed. associated side-effects to be minimized. The effectiveness The provisional conclusion must be that, in RA patients of low-dose therapy in reducing joint destruction [57], who also have Cushing's or Addison's diseases, there is together with an improved understanding of the timing no clear-cut correlation between cortisol levels and of drug delivery [58, 59] , may hold the key to the severity of disease. One study using chemical adrenaleccontainment of RA. Finally, if we are to gain insight tomy with metyrapone resulted in a significant deteriorainto any pathological inability of the HPA axis to tion in RA symptoms, implying that endogenous control inflammation during RA, it may not be sufficient glucocorticoids can exert ant-inflammatory effects [48] .
to limit measurements to ACTH and cortisol, but rather Another 'experiment of nature' is to observe the to challenge the whole axis with stressors and measure effects of chronic psychological stress on RA. It is now a range of hormonal and immune responses. This will apparent that the indisputable anti-inflammatory effects enable a profile to be developed of the stress response of exogenously administered synthetic glucocorticoids in RA compared to that in healthy subjects. If the on RA are not necessarily mirrored by increased secreresponses to certain stressors are weighted towards tion of endogenous glucocorticoids in response to stress.
the release of pro-inflammatory compounds in RA Women can mount a more robust cortisol response than compared to healthy controls, identification of these men to many types of stress [49] [50] [51] , yet the majority compounds might provide valuable information about of patients with RA are female. If elevated secretion of useful antagonists, and the timings of their use, in the endogenous cortisol is anti-inflammatory, a more robust response to stress ought to be protective in women with treatment of this complex disease.
